Dr. Mark provides strategic and operational leadership for pharmacy services across 10 hospitals, nine outpatient pharmacies, and 17 infusion centers. She drives safety, standardization, and regulatory excellence while advancing technology enablement across the medication-use process. Dr. Mark has led major platform standardizations, including BD devices, IV/syringe/PCA pumps and Omnicell, and executed multiple new-build and renovation projects. In 2024, she surpassed financial targets with $16.7 million in savings and revenue optimization while expanding clinical pharmacy services and governance. Her portfolio includes ambulatory growth, centralized prior authorization and refill operations, anticoagulation services, and medication policy stewardship, all aligned to 340B compliance. Dr. Mark also serves on the dean’s advisory board at Duquesne University and previously held leadership roles at several hospitals and at McKesson Med Management.
